SymBio Pharmaceuticals Limited 4582Short Interest
Estimated short interest in SymBio Pharmaceuticals Limited (4582) is 9.46% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Morgan Stanley MUFG Securities Co., Ltd., Nomura International plc, Barclays Capital Securities Ltd and 4 others.
Estimated short interest
9.46%
±0.00%
Estimated position (shares)
9,155,924
As of 2026-11-18
Holders (0.5% or more)
7 firms
5136 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 11 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-30 |
|---|---|
| Latest disclosure | 2026-11-17 (Morgan Stanley MUFG Securities Co., Ltd., 2.68%) |
| Reporting institutions | 22 firms (5136 reports) |
| Peak estimated short interest | 16.07% (2022-08-04, 8 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Morgan Stanley MUFG Securities Co., Ltd.
- Nomura International plc
- Barclays Capital Securities Ltd
- JPM Securities Japan Co Ltd.
- GOLDMAN SACHS INTERNATIONAL
- Others
9.46%
Estimated short interest, 2026-11-18
Others1.13%
GOLDMAN SACHS INTERNATIONAL0.89%
JPM Securities Japan Co Ltd.1.12%
Barclays Capital Securities Ltd1.44%
Nomura International plc2.20%
Morgan Stanley MUFG Securities Co., Ltd.2.68%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 2,271,927 shares | Ratio 2.68% | ▲0.16% | Holding |
| 2026-11-16 | Nomura International plc | Position 2,230,021 shares | Ratio 2.20% | ▲0.59% | Holding |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 1,463,025 shares | Ratio 1.44% | ▲0.42% | Holding |
| 2026-11-16 | JPM Securities Japan Co Ltd. | Position 1,131,951 shares | Ratio 1.12% | ▲0.41% | Holding |
| 2026-11-16 | GOLDMAN SACHS INTERNATIONAL | Position 900,300 shares | Ratio 0.89% | ▲0.54% | Holding |
| 2026-11-16 | UBS AG | Position 595,900 shares | Ratio 0.58% | ▲0.26% | Holding |
| 2026-11-16 | Citigroup Global Markets Limited | Position 562,800 shares | Ratio 0.55% | ▲0.07% | Holding |
| 2021-08-23 | Deutsche Bank Aktiengesellschaft, London | Position 190,000 shares | Ratio 0.49% | ▼0.13% | Below 0.5% |
| 2024-09-03 | XTX Markets Pte Ltd | Position 229,400 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2018-05-18 | OXAM QUANT FUND LIMITED | Position 285,000 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2026-03-19 | MERRILL LYNCH INTERNATIONAL | Position 340,699 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2023-05-30 | PDT Partners, LLC | Position 185,100 shares | Ratio 0.46% | ▼0.05% | Below 0.5% |
| 2022-08-08 | Credit Suisse AG | Position 171,775 shares | Ratio 0.43% | ▼0.23% | Below 0.5% |
| 2017-10-24 | JPMorgan Securities Japan Co., Ltd. | Position 193,000 shares | Ratio 0.38% | ▼0.14% | Below 0.5% |
| 2024-08-05 | BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC | Position 160,000 shares | Ratio 0.34% | ▼0.40% | Below 0.5% |
| 2026-02-24 | JANE STREET GLOBAL TRADING, LLC | Position 222,175 shares | Ratio 0.32% | ▼0.20% | Below 0.5% |
| 2019-12-06 | Credit Suisse Securities (Japan) Limited | Position 81,300 shares | Ratio 0.32% | ▼0.85% | Below 0.5% |
| 2022-08-10 | BNP Paribas Arbitrage SNC | Position 74,500 shares | Ratio 0.18% | ▼0.39% | Below 0.5% |
| 2019-11-28 | Credit Suisse Securities (Europe) Limited | Position 0 shares | Ratio 0.00% | ▼0.59% | Closed |
| 2018-11-05 | Barclays Securities Japan Limited (BSJL) | Position 0 shares | Ratio 0.00% | ▼2.41% | Closed |
| 2024-04-19 | Evo Fund | Position 0 shares | Ratio 0.00% | ▼1.73% | Closed |
| 2026-03-31 | Macquarie Bank Limited | Position 0 shares | Ratio 0.00% | ▼0.79% | Closed |
Disclosure History 5136 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 2,271,927 shares | Ratio 2.68% | ▲0.16% | — |
| 2026-11-16 | UBS AG | Position 595,900 shares | Ratio 0.58% | ▲0.26% | — |
| 2026-11-16 | Nomura International plc | Position 2,230,021 shares | Ratio 2.20% | ▲0.59% | — |
| 2026-11-16 | JPM Securities Japan Co Ltd. | Position 1,131,951 shares | Ratio 1.12% | ▲0.41% | — |
| 2026-11-16 | GOLDMAN SACHS INTERNATIONAL | Position 900,300 shares | Ratio 0.89% | ▲0.54% | — |
| 2026-11-16 | Citigroup Global Markets Limited | Position 562,800 shares | Ratio 0.55% | ▲0.07% | — |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 1,463,025 shares | Ratio 1.44% | ▲0.42% | — |
| 2026-11-13 | Nomura International plc | Position 1,629,024 shares | Ratio 1.61% | ▲0.32% | — |
| 2026-11-13 | Barclays Capital Securities Ltd | Position 1,030,825 shares | Ratio 1.02% | ▲0.44% | — |
| 2026-11-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 2,139,027 shares | Ratio 2.52% | ▲0.54% | — |
| 2026-11-12 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,676,127 shares | Ratio 1.98% | ▼0.02% | — |
| 2026-11-12 | Barclays Capital Securities Ltd | Position 594,925 shares | Ratio 0.58% | ▲0.20% | — |
| 2026-11-11 | Nomura International plc | Position 1,312,515 shares | Ratio 1.29% | ▼0.15% | — |
| 2026-11-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,694,327 shares | Ratio 2.00% | ▲0.14% | — |
| 2026-11-10 | Nomura International plc | Position 1,463,019 shares | Ratio 1.44% | ▼0.69% | — |
| 2026-11-10 | JPM Securities Japan Co Ltd. | Position 725,651 shares | Ratio 0.71% | ▲0.13% | — |
| 2026-11-10 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,572,627 shares | Ratio 1.86% | ▲0.17% | — |
| 2026-11-09 | Nomura International plc | Position 2,159,216 shares | Ratio 2.13% | ▼0.16% | — |
| 2026-11-09 | JPM Securities Japan Co Ltd. | Position 589,451 shares | Ratio 0.58% | ▲0.14% | — |
| 2026-11-09 | Citigroup Global Markets Limited | Position 489,100 shares | Ratio 0.48% | ▼0.06% | Below 0.5% |
| 2026-11-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,432,027 shares | Ratio 1.69% | ▲0.60% | — |
| 2026-11-06 | Nomura International plc | Position 2,002,568 shares | Ratio 2.29% | ▲0.24% | — |
| 2026-11-06 | Citigroup Global Markets Limited | Position 479,800 shares | Ratio 0.54% | ▲0.05% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 379,725 shares | Ratio 0.43% | ▼0.16% | Below 0.5% |
| 2026-11-06 | Morgan Stanley MUFG Securities Co., Ltd. | Position 927,227 shares | Ratio 1.09% | ▲0.64% | — |
| 2026-11-05 | Barclays Capital Securities Ltd | Position 519,925 shares | Ratio 0.59% | ▼0.36% | — |
| 2026-11-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 381,127 shares | Ratio 0.45% | ▼0.08% | Below 0.5% |
| 2026-11-04 | Nomura International plc | Position 1,793,926 shares | Ratio 2.05% | ▼0.07% | — |
| 2026-11-04 | Barclays Capital Securities Ltd | Position 831,725 shares | Ratio 0.95% | ▼0.11% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 901,925 shares | Ratio 1.06% | ▲0.14% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
| Renascience Inc.4889 | 6.87% | 3 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| CanBas Co.,Ltd.4575 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| D.Western Therapeutics Institute, Inc.4576 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Daito Pharmaceutical Co.,Ltd.4577 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| Otsuka Holdings Co.,Ltd.4578 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| RaQualia Pharma Inc.4579 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chiome Bioscience Inc.4583 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Medrx Co.,Ltd.4586 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PeptiDream Inc.4587 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Oncolys BioPharma Inc.4588 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |